This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dainippon Sumitomo Pharma Co., Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Kazuya Otoda: Innovator in Pharmaceutical Solutions
Introduction
Kazuya Otoda is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work has led to advancements that benefit both the medical community and patients.
Latest Patents
Kazuya Otoda holds a patent for a solubilization preparation. This preparation is a solution-type formulation of lurasidone, which includes N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1'R,2'S,3'R,4'S)-2,3-bicyclo[2,2,1]heptanedicarboxyimide hydrochloride as the active ingredient. The formulation also contains at least one substance selected from benzyl alcohol, N,N-dimethylacetamide, lactic acid, and propylene glycol. This patent showcases his expertise in creating effective pharmaceutical solutions.
Career Highlights
Kazuya Otoda is associated with Dainippon Sumitomo Pharma Co., Ltd., where he has been instrumental in research and development. His career is marked by a commitment to innovation and excellence in the pharmaceutical industry. His contributions have not only advanced drug formulations but have also enhanced therapeutic options available to patients.
Collaborations
Throughout his career, Kazuya has collaborated with talented individuals such as Takashi Nakagawa and Mayumi Nakamura. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, leading to successful innovations in the field.
Conclusion
Kazuya Otoda's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for a solubilization preparation of lurasidone highlights his dedication to improving drug formulations. Through his career and collaborations, he continues to make a significant impact in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile